
|Videos|May 16, 2014
Personalized Therapies in Advanced Breast Cancer
Author(s)Debu Tripathy, MD
Debu Tripathy, MD, co-leader, Women's Cancer Program, University of Southern California Norris Comprehensive Cancer Center, discusses new personalized therapies on the horizon for advanced breast cancer.
Advertisement
Debu Tripathy, MD, co-leader, Women's Cancer Program, University of Southern California Norris Comprehensive Cancer Center, discusses new personalized therapies on the horizon for advanced breast cancer.
Clinical Pearls:
- Physicians have known for some time that there are molecular targets that are amenable to therapy
- Now that the entire genome can be sequenced, physicians are understanding more about mutations in breast cancer
- Upon sequencing the tumors of many patients with breast cancer, physicians are finding that no two tumors are the same
- New mutations may be picked up after analyzing a patient’s tumor after treatment
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5







































